Copyright Reports & Markets. All rights reserved.

Global Angiotensin Receptor Blockers (ARBs) Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Angiotensin Receptor Blockers (ARBs)

      • 1.1 Definition of Angiotensin Receptor Blockers (ARBs)
      • 1.2 Angiotensin Receptor Blockers (ARBs) Segment by Type
        • 1.2.1 Global Angiotensin Receptor Blockers (ARBs) Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Valsartan
        • 1.2.3 Telmisartan
        • 1.2.4 Losartan
        • 1.2.5 Irbesartan
        • 1.2.6 Azilsartan
        • 1.2.7 Olmesartan
      • 1.3 Angiotensin Receptor Blockers (ARBs) Segment by Applications
        • 1.3.1 Global Angiotensin Receptor Blockers (ARBs) Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hypertension
        • 1.3.3 Cardiovascular Diseases
        • 1.3.4 Kidney Diseases
        • 1.3.5 Other
      • 1.4 Global Angiotensin Receptor Blockers (ARBs) Overall Market
        • 1.4.1 Global Angiotensin Receptor Blockers (ARBs) Revenue (2014-2025)
        • 1.4.2 Global Angiotensin Receptor Blockers (ARBs) Production (2014-2025)
        • 1.4.3 North America Angiotensin Receptor Blockers (ARBs) Status and Prospect (2014-2025)
        • 1.4.4 Europe Angiotensin Receptor Blockers (ARBs) Status and Prospect (2014-2025)
        • 1.4.5 China Angiotensin Receptor Blockers (ARBs) Status and Prospect (2014-2025)
        • 1.4.6 Japan Angiotensin Receptor Blockers (ARBs) Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Angiotensin Receptor Blockers (ARBs) Status and Prospect (2014-2025)
        • 1.4.8 India Angiotensin Receptor Blockers (ARBs) Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Angiotensin Receptor Blockers (ARBs)
      • 2.3 Manufacturing Process Analysis of Angiotensin Receptor Blockers (ARBs)
      • 2.4 Industry Chain Structure of Angiotensin Receptor Blockers (ARBs)

      3 Development and Manufacturing Plants Analysis of Angiotensin Receptor Blockers (ARBs)

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Angiotensin Receptor Blockers (ARBs) Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Angiotensin Receptor Blockers (ARBs)
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Angiotensin Receptor Blockers (ARBs) Production and Capacity Analysis
      • 4.2 Angiotensin Receptor Blockers (ARBs) Revenue Analysis
      • 4.3 Angiotensin Receptor Blockers (ARBs) Price Analysis
      • 4.4 Market Concentration Degree

      5 Angiotensin Receptor Blockers (ARBs) Regional Market Analysis

      • 5.1 Angiotensin Receptor Blockers (ARBs) Production by Regions
        • 5.1.1 Global Angiotensin Receptor Blockers (ARBs) Production by Regions
        • 5.1.2 Global Angiotensin Receptor Blockers (ARBs) Revenue by Regions
      • 5.2 Angiotensin Receptor Blockers (ARBs) Consumption by Regions
      • 5.3 North America Angiotensin Receptor Blockers (ARBs) Market Analysis
        • 5.3.1 North America Angiotensin Receptor Blockers (ARBs) Production
        • 5.3.2 North America Angiotensin Receptor Blockers (ARBs) Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Angiotensin Receptor Blockers (ARBs) Import and Export
      • 5.4 Europe Angiotensin Receptor Blockers (ARBs) Market Analysis
        • 5.4.1 Europe Angiotensin Receptor Blockers (ARBs) Production
        • 5.4.2 Europe Angiotensin Receptor Blockers (ARBs) Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Angiotensin Receptor Blockers (ARBs) Import and Export
      • 5.5 China Angiotensin Receptor Blockers (ARBs) Market Analysis
        • 5.5.1 China Angiotensin Receptor Blockers (ARBs) Production
        • 5.5.2 China Angiotensin Receptor Blockers (ARBs) Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Angiotensin Receptor Blockers (ARBs) Import and Export
      • 5.6 Japan Angiotensin Receptor Blockers (ARBs) Market Analysis
        • 5.6.1 Japan Angiotensin Receptor Blockers (ARBs) Production
        • 5.6.2 Japan Angiotensin Receptor Blockers (ARBs) Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Angiotensin Receptor Blockers (ARBs) Import and Export
      • 5.7 Southeast Asia Angiotensin Receptor Blockers (ARBs) Market Analysis
        • 5.7.1 Southeast Asia Angiotensin Receptor Blockers (ARBs) Production
        • 5.7.2 Southeast Asia Angiotensin Receptor Blockers (ARBs) Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Angiotensin Receptor Blockers (ARBs) Import and Export
      • 5.8 India Angiotensin Receptor Blockers (ARBs) Market Analysis
        • 5.8.1 India Angiotensin Receptor Blockers (ARBs) Production
        • 5.8.2 India Angiotensin Receptor Blockers (ARBs) Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Angiotensin Receptor Blockers (ARBs) Import and Export

      6 Angiotensin Receptor Blockers (ARBs) Segment Market Analysis (by Type)

      • 6.1 Global Angiotensin Receptor Blockers (ARBs) Production by Type
      • 6.2 Global Angiotensin Receptor Blockers (ARBs) Revenue by Type
      • 6.3 Angiotensin Receptor Blockers (ARBs) Price by Type

      7 Angiotensin Receptor Blockers (ARBs) Segment Market Analysis (by Application)

      • 7.1 Global Angiotensin Receptor Blockers (ARBs) Consumption by Application
      • 7.2 Global Angiotensin Receptor Blockers (ARBs) Consumption Market Share by Application (2014-2019)

      8 Angiotensin Receptor Blockers (ARBs) Major Manufacturers Analysis

      • 8.1 Pfizer
        • 8.1.1 Pfizer Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.1.2 Pfizer Product Introduction, Application and Specification
        • 8.1.3 Pfizer Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Novartis
        • 8.2.1 Novartis Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.2.2 Novartis Product Introduction, Application and Specification
        • 8.2.3 Novartis Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Merck
        • 8.3.1 Merck Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.3.2 Merck Product Introduction, Application and Specification
        • 8.3.3 Merck Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Astra Zeneca
        • 8.4.1 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.4.2 Astra Zeneca Product Introduction, Application and Specification
        • 8.4.3 Astra Zeneca Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Jhonson and Johnson
        • 8.5.1 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.5.2 Jhonson and Johnson Product Introduction, Application and Specification
        • 8.5.3 Jhonson and Johnson Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Eli Lilly
        • 8.6.1 Eli Lilly Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.6.2 Eli Lilly Product Introduction, Application and Specification
        • 8.6.3 Eli Lilly Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Sanofi
        • 8.7.1 Sanofi Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.7.2 Sanofi Product Introduction, Application and Specification
        • 8.7.3 Sanofi Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Bristol-Myers Squibb
        • 8.8.1 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.8.2 Bristol-Myers Squibb Product Introduction, Application and Specification
        • 8.8.3 Bristol-Myers Squibb Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Bayer
        • 8.9.1 Bayer Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.9.2 Bayer Product Introduction, Application and Specification
        • 8.9.3 Bayer Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 GSK
        • 8.10.1 GSK Angiotensin Receptor Blockers (ARBs) Production Sites and Area Served
        • 8.10.2 GSK Product Introduction, Application and Specification
        • 8.10.3 GSK Angiotensin Receptor Blockers (ARBs) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Teva Pharmaceutical

      9 Development Trend of Analysis of Angiotensin Receptor Blockers (ARBs) Market

      • 9.1 Global Angiotensin Receptor Blockers (ARBs) Market Trend Analysis
        • 9.1.1 Global Angiotensin Receptor Blockers (ARBs) Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Angiotensin Receptor Blockers (ARBs) Regional Market Trend
        • 9.2.1 North America Angiotensin Receptor Blockers (ARBs) Forecast 2019-2025
        • 9.2.2 Europe Angiotensin Receptor Blockers (ARBs) Forecast 2019-2025
        • 9.2.3 China Angiotensin Receptor Blockers (ARBs) Forecast 2019-2025
        • 9.2.4 Japan Angiotensin Receptor Blockers (ARBs) Forecast 2019-2025
        • 9.2.5 Southeast Asia Angiotensin Receptor Blockers (ARBs) Forecast 2019-2025
        • 9.2.6 India Angiotensin Receptor Blockers (ARBs) Forecast 2019-2025
      • 9.3 Angiotensin Receptor Blockers (ARBs) Market Trend (Product Type)
      • 9.4 Angiotensin Receptor Blockers (ARBs) Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Angiotensin Receptor Blockers (ARBs) Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Angiotensin II receptor blockers (ARBs), also known as angiotensin II receptor antagonists, AT1 receptor antagonists or sartans, are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.

        The global Angiotensin Receptor Blockers (ARBs) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Angiotensin Receptor Blockers (ARBs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Angiotensin Receptor Blockers (ARBs) market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Angiotensin Receptor Blockers (ARBs) in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Angiotensin Receptor Blockers (ARBs) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Pfizer
        Novartis
        Merck
        Astra Zeneca
        Jhonson and Johnson
        Eli Lilly
        Sanofi
        Bristol-Myers Squibb
        Bayer
        GSK
        Teva Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Valsartan
        Telmisartan
        Losartan
        Irbesartan
        Azilsartan
        Olmesartan

        Segment by Application
        Hypertension
        Cardiovascular Diseases
        Kidney Diseases
        Other

        Buy now